183 related articles for article (PubMed ID: 29278339)
1. Determinants of Patient's Global Assessment of Disease Activity and Physician's Global Assessment of Disease Activity in patients with rheumatoid arthritis: A post hoc analysis of overall and Japanese results from phase 3 clinical trials.
Kaneko Y; Takeuchi T; Cai Z; Sato M; Awakura K; Gaich C; Zhu B; Guo J; Tanaka Y
Mod Rheumatol; 2018 Nov; 28(6):960-967. PubMed ID: 29278339
[TBL] [Abstract][Full Text] [Related]
2. Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort.
Markenson JA; Koenig AS; Feng JY; Chaudhari S; Zack DJ; Collier D; Weaver A
J Clin Rheumatol; 2013 Sep; 19(6):317-23. PubMed ID: 23965479
[TBL] [Abstract][Full Text] [Related]
3. Discordance between the patient's and physician's global assessment in rheumatoid arthritis: Data from the REAL study-Brazil.
Guimarães MFBR; Pinto MRDC; Resende GG; Machado CJ; Vargas-Santos AB; Amorim RBC; Gomides APM; Albuquerque CP; Bértolo MB; Júnior PL; Santos IA; Giorgi RDN; Saciloto NC; Radominski SC; Borghi FM; Bonfiglioli KR; Silva HCD; Sauma MFLDC; Sauma ML; Medeiros JB; Pereira IA; Castro GRW; Brenol CV; Xavier RM; Mota LMH; Castelar-Pinheiro GDR
PLoS One; 2020; 15(3):e0230317. PubMed ID: 32168350
[TBL] [Abstract][Full Text] [Related]
4. Relationship between disease activity and patient-reported outcomes in rheumatoid arthritis: Post hoc analyses of overall and Japanese results from two phase 3 clinical trials.
Ishiguro N; Dougados M; Cai Z; Zhu B; Ishida M; Sato M; Gaich C; Quebe A; Stoykov I; Tanaka Y
Mod Rheumatol; 2018 Nov; 28(6):950-959. PubMed ID: 29278006
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative.
Akhavan PS; Movahedi M; Cesta A; Bombardier C;
Clin Exp Rheumatol; 2023 Nov; 41(11):2249-2256. PubMed ID: 37382462
[TBL] [Abstract][Full Text] [Related]
6. Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate.
Kaeley GS; Nishio MJ; Goyal JR; MacCarter DK; Wells AF; Chen S; Kupper H; Kalabic J
Arthritis Rheumatol; 2016 Nov; 68(11):2584-2592. PubMed ID: 27214046
[TBL] [Abstract][Full Text] [Related]
7. Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial.
Strand V; Kosinski M; Chen CI; Joseph G; Rendas-Baum R; Graham NM; van Hoogstraten H; Bayliss M; Fan C; Huizinga T; Genovese MC
Arthritis Res Ther; 2016 Sep; 18(1):198. PubMed ID: 27600829
[TBL] [Abstract][Full Text] [Related]
8. Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib.
Strand V; Kaine J; Alten R; Wallenstein G; Diehl A; Shi H; Germino R; Murray CW
Arthritis Res Ther; 2020 Oct; 22(1):243. PubMed ID: 33059710
[TBL] [Abstract][Full Text] [Related]
9. Influence of large joint involvement on patient-physician discordance in global assessment of rheumatoid arthritis disease activity analyzed by a novel joint index.
Tago M; Sawada T; Nishiyama S; Tahara K; Kato E; Hayashi H; Mori H; Nishino J; Matsui T; Tohma S
Int J Rheum Dis; 2018 Jun; 21(6):1237-1245. PubMed ID: 29611628
[TBL] [Abstract][Full Text] [Related]
10. Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI).
Pope JE; Rampakakis E; Movahedi M; Cesta A; Sampalis JS; Bombardier C;
Rheumatology (Oxford); 2021 Feb; 60(2):717-727. PubMed ID: 32789456
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment.
Schiff M; Takeuchi T; Fleischmann R; Gaich CL; DeLozier AM; Schlichting D; Kuo WL; Won JE; Carmack T; Rooney T; Durez P; Shaikh S; Hidalgo RP; van Vollenhoven R; Zerbini CAF
Arthritis Res Ther; 2017 Sep; 19(1):208. PubMed ID: 28923098
[TBL] [Abstract][Full Text] [Related]
12. Impact of Patient's Global Assessment on Achieving Remission in Patients With Rheumatoid Arthritis: A Multinational Study Using the METEOR Database.
Ferreira RJO; Carvalho PD; Ndosi M; Duarte C; Chopra A; Murphy E; van der Heijde D; Machado PM; da Silva JAP
Arthritis Care Res (Hoboken); 2019 Oct; 71(10):1317-1325. PubMed ID: 30821895
[TBL] [Abstract][Full Text] [Related]
13. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
[TBL] [Abstract][Full Text] [Related]
14. Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients.
Eder L; Thavaneswaran A; Chandran V; Cook R; Gladman DD
Arthritis Care Res (Hoboken); 2015 Feb; 67(2):264-72. PubMed ID: 25047020
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
Keystone EC; Taylor PC; Tanaka Y; Gaich C; DeLozier AM; Dudek A; Zamora JV; Cobos JAC; Rooney T; Bono S; Arora V; Linetzky B; Weinblatt ME
Ann Rheum Dis; 2017 Nov; 76(11):1853-1861. PubMed ID: 28798049
[TBL] [Abstract][Full Text] [Related]
16. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study.
Strand V; Rentz AM; Cifaldi MA; Chen N; Roy S; Revicki D
J Rheumatol; 2012 Jan; 39(1):63-72. PubMed ID: 22045836
[TBL] [Abstract][Full Text] [Related]
18. Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity.
Smolen JS; Strand V; Koenig AS; Szumski A; Kotak S; Jones TV
Arthritis Res Ther; 2016 May; 18(1):114. PubMed ID: 27209012
[TBL] [Abstract][Full Text] [Related]
19. A multicentre observational study comparing patient reported outcomes to assess reliability of swollen and tender joint assessments and response to certolizumab treatment as compared to clinician assessments in rheumatoid arthritis.
Inderjeeth CA; Inderjeeth AJ; Raymond WD
Int J Rheum Dis; 2019 Jan; 22(1):73-80. PubMed ID: 30187688
[TBL] [Abstract][Full Text] [Related]
20. Discordance of Global Assessments by Patient and Physician Is Higher in Female than in Male Patients Regardless of the Physician's Sex: Data on Patients with Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis from the DANBIO Registry.
Lindström Egholm C; Krogh NS; Pincus T; Dreyer L; Ellingsen T; Glintborg B; Kowalski MR; Lorenzen T; Madsen OR; Nordin H; Rasmussen C; Hetland ML
J Rheumatol; 2015 Oct; 42(10):1781-5. PubMed ID: 26233511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
